Abstract:Mutations in the KCNQ2 gene encoding K V 7.2 subunit that mediates neuronal M-current cause a severe form of developmental and epileptic encephalopathy (DEE). Electrophysiological evaluation of KCNQ2 mutations has been proved clinically useful in improving outcome prediction and choosing rational anti-seizure medications (ASMs). In this study we described the clinical characteristics, electrophysiological phenotypes and the in vitro response to KCNQ openers of five KCNQ2 pore mutations (V250A, N258Y, H260P, A265T and G290S) from seven patients diagnosed with KCNQ2-DEE. The KCNQ2 variants were transfected into Chinese hamster ovary (CHO) cells alone, in combination with KCNQ3 (1:1) or with wild-type KCNQ2 (KCNQ2-WT) and KCNQ3 in a ratio of 1:1:2, respectively. Their expression and electrophysiological function were assessed. When transfected alone or in combination with KCNQ3, none of these mutations affected the membrane expression of KCNQ2, but most failed to induce a potassium current except A265T, in which trace currents were observed when co-transfected with KCNQ3. When co-expressed with KCNQ2-WT and KCNQ3 (1:1:2), the currents at 0 mV of these mutations were decreased by 30%-70% compared to the KCNQ2/3 channel, which could be significantly rescued by applying KCNQ openers including the approved antiepileptic drug retigabine (RTG, 10 μM), as well as two candidates subjected to clinical trials, pynegabine (HN37, 1 μM) and XEN1101 (1 μM). These newly identified pathologic variants enrich the KCNQ2-DEE mutation hotspots in the pore-forming domain. This electrophysiological study provides a rational basis for personalized therapy with KCNQ openers in DEE patients carrying loss-of-function (LOF) mutations in KCNQ2.

Generation of three induced pluripotent stem cell lines from a patient with KCNQ2 developmental and epileptic encephalopathy as a result of the pathogenic variant c.881C > T; p.Ala294Val (NUIGi059-A, NUIGi059-B, NUIGi059-C) and 3 healthy controls (NUIGi060-A, NUIGi060-B, NUIGi060-C)

Generation of three induced pluripotent stem cell lines from a patient with KCNQ2 developmental and epileptic encephalopathy as a result of the pathogenic variant c.638C > T; p.Arg213Gln (NUIGi063-A, NUIGi063-B, NUIGi063-C) and 3 healthy controls (NUIGi064-A, NUIGi064-B, NUIGi064-C)

An iPSC line (FINi003-A) from a male with late-onset developmental and epileptic encephalopathy caused by a heterozygous p.E1211K variant in the SCN2A gene encoding the voltage-gated sodium channel Na v 1.2

Generation of an Induced Pluripotent Stem Cell Line (FDCHI007-A) Derived from a Patient with Developmental and Epileptic Encephalopathy Type 31 Carrying Heterozygous C.545c > A Mutation in DNM1 Gene

Generation of a Human Ipsc Line from an Epileptic Encephalopathy Patient with Electrical Status Epilepticus During Sleep Carrying KCNA2 (p.p405l) Mutation.

Generation of two patient specific GABRD variants and their isogenic controls for modeling epilepsy

Generation of an Induced Pluripotent Stem Cell Line from a Long QT Syndrome Patient Carrying KCNH2/1956C > A Mutation.

Investigation of novel de novo KCNC2 variants causing severe developmental and early-onset epileptic encephalopathy

Induced pluripotent stem cells (SHCDNi006-A cells) isolated from the peripheral blood mononuclear cells of a five-month-old Chinese girl with the heterozygous missense mutation (c.2800 G>A) in the KCNT1 gene

Identification of a novel KCNT2 variant in a family with developmental and epileptic encephalopathies: a case report and literature review

Clinical analysis and functional characterization of KCNQ2-related developmental and epileptic encephalopathy

Generation of a Human Ipsc Line CIPi003-A from a Patient with Focal Epilepsy Harboring a Heterozygous Mutation in DEPDC5 Gene.

An induced pluripotent stem cell line (EHTJUi004-A) generated from a neonate with c.4683_4684delCT:p.Leu1563fs mutation in the gene <i>DSP</i> causing Familial Arrhythmogenic Right Ventricular Dysplasia (ARVD)

Establishment Of An Induced Pluripotent Stem Cell Line (Zjshi001-A) From A Patient With Epileptic Encephalopathy Carrying Kcnb1 Glu330asp Mutation

Derivation of an induced pluripotent stem cell line (FDCHi014-A) from PBMCs of a seven-year-old patient with a truncating NOVA2 variant (c.625del)

Generation of Three Ipsc Lines (Xachi007-A, XACHi008-A, XACHi009-A) from a Chinese Family with Long QT Syndrome Type 5 with Heterozygous C.226g>a (p.d76n) Mutation in KCNE1gene.

Functional characterization and in vitro pharmacological rescue of KCNQ2 pore mutations associated with epileptic encephalopathy

Generation of a Human Ipsc Line (Zjshdpi001-A) from Peripheral Blood Mononuclear Cells of a Patient with Developmental Epileptic Encephalopathy-47 Carrying FGF12 Gene Mutation (c.334g > A)

Generation of a Human Induced Pluripotent Stem Cell Line (Cipi002-A) from an Early Infantile Epileptic Encephalopathy Patient with a Heterozygous Mutation in SCN8A

Establishment and characterization of ZJUCHi003: an induced pluripotent stem cell line from a patient with Temple–Baraitser/Zimmermann–Laband syndrome carrying KCNH1 c.1070G > A (p.R357Q) variant

Novel KCNQ2 Missense Variant Expands the Genotype Spectrum of DEE7.